We are live on ! Find out more
ABBV icon

AbbVie
ABBV

1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0% → 68.14% (+68%)

33% more call options, than puts

Call options by funds: $182M | Put options by funds: $137M

Holders
1,286
Holders Change
+1,286
Holders Change %
–
% of All Funds
41.97%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,286
Increased
–
Reduced
–
Closed
–
Calls
$182M
Puts
$137M
Net Calls
+$45.2M
Net Calls Change
+$45.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CB
201
Commerce Bank
Missouri
$19.9M +$21.1M +482,054 New
WBC
202
Westpac Banking Corp
Australia
$19.9M +$21.3M +486,658 New
QBFM
203
QS Batterymarch Financial Management
New York
$19.9M +$21M +480,428 New
RFC
204
Regions Financial Corp
Alabama
$19.5M +$20.7M +472,710 New
FAM
205
Fred Alger Management
New York
$19.3M +$20.4M +466,371 New
KBC Group
206
KBC Group
Belgium
$19.2M +$20.3M +464,315 New
NTCOC
207
Northern Trust Company of Connecticut
Connecticut
$19.1M +$20.2M +462,782 New
WT
208
Whittier Trust
California
$19.1M +$20.2M +462,437 New
AAMU
209
AEGON Asset Management (UK)
United Kingdom
$18.8M +$19.9M +455,117 New
DCLA
210
Douglas C. Lane & Associates
New York
$18.8M +$19.9M +454,270 New
BA
211
Boston Advisors
Massachusetts
$18.6M +$19.7M +450,232 New
FIM
212
Foresters Investment Management
New York
$18.3M +$19.4M +443,000 New
EIM
213
ExxonMobil Investment Management
Texas
$18.2M +$19.2M +440,079 New
WT
214
Wilmington Trust
Delaware
$18.2M +$19.2M +439,080 New
PMAM
215
Picton Mahoney Asset Management
Ontario, Canada
$18.1M +$19.1M +437,300 New
Two Sigma Investments
216
Two Sigma Investments
New York
$18.1M +$19.1M +437,303 New
SAM
217
Shell Asset Management
Netherlands
$17.9M +$19M +433,986 New
TAM
218
Tiverton Asset Management
Delaware
$17.8M +$18.8M +430,000 New
JMPWA
219
JP Morgan Private Wealth Advisors
California
$17.6M +$18.6M +425,184 New
HPC
220
HM Payson & Co
Maine
$17.4M +$18.4M +421,105 New
MA
221
MUFG Americas
New York
$17.4M +$18.4M +420,462 New
ST
222
Sabal Trust
Florida
$17.3M +$18.3M +419,564 New
HFS
223
HL Financial Services
Kentucky
$17.3M +$18.3M +418,307 New
HT
224
HAP Trading
New York
$17.2M +$18.2M +416,248 New
FT
225
Fiduciary Trust
Massachusetts
$16.8M +$17.8M +406,744 New
7 8
9
10 11

ABBV Hedge Fund Activity: Q2 2013 in Review

1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.

Based on aggregated 13F filings for Q2 2013.